Finance

Lists
300601:SHE
Shenzhen Kangtai Biological Prods Co Ltd
12,43 CN¥
-0,56%
(-0,070) 1D
16 հոկ, 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300601...
Open
12,59 CN¥
High
13,00 CN¥
Low
12,30 CN¥
Mkt. cap
13,88 մլրդ
Avg. vol.
19,76 մլն
Volume
20,15 մլն
P/E ratio
165,53
52-wk high
17,76 CN¥
52-wk low
10,70 CN¥
EPS
0,08 CN¥
Shares outstanding
1,12 մլրդ
No. of employees
2 հզր
Open
12,59 CN¥
High
13,00 CN¥
Low
12,30 CN¥
Mkt. cap
13,88 մլրդ
Avg. vol.
19,76 մլն
Volume
20,15 մլն
P/E ratio
165,53
52-wk high
17,76 CN¥
52-wk low
10,70 CN¥
EPS
0,08 CN¥
Shares outstanding
1,12 մլրդ
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
About Shenzhen Kangtai Biological Prods Co Ltd
CEO-
Employees1,96 հզր
Founded08 սեպ, 1992 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
671,38 մլն
609,64 մլն
631,11 մլն
641,89 մլն
Cost of goods sold
110,97 մլն
267,74 մլն
182,40 մլն
218,78 մլն
Cost of revenue
110,97 մլն
267,74 մլն
182,40 մլն
218,78 մլն
Research and development expenses
123,15 մլն
123,35 մլն
84,28 մլն
90,88 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
291,37 մլն
283,35 մլն
302,79 մլն
284,34 մլն
Operating expense
425,29 մլն
428,59 մլն
406,24 մլն
402,08 մլն
Total operating expenses
536,26 մլն
696,33 մլն
588,65 մլն
620,87 մլն
Operating income
135,12 մլն
-86,69 մլն
42,47 մլն
21,03 մլն
Other non operating income
-375,71 հզր
308,38 հզր
-2,04 մլն
1,69 մլն
EBT including unusual items
324,22 հզր
45,26 մլն
39,95 մլն
1,37 մլն
EBT excluding unusual items
125,91 մլն
-104,26 մլն
19,66 մլն
-1,09 մլն
Income tax expense
-11,26 մլն
24,17 մլն
6,35 մլն
-12,75 մլն
Effective tax rate
-3 472,08%
53,40%
15,89%
-932,00%
Other operating expenses
3,89 մլն
14,05 մլն
6,96 մլն
12,14 մլն
Net income
11,62 մլն
21,17 մլն
33,34 մլն
17,05 մլն
Net profit margin
1,73%
3,47%
5,28%
2,66%
Earnings per share
-
-
-
-
Interest and investment income
20,88 մլն
13,75 մլն
8,72 մլն
9,41 մլն
Interest expense
-30,13 մլն
-30,16 մլն
-29,50 մլն
-29,76 մլն
Net interest expenses
-9,24 մլն
-16,42 մլն
-20,77 մլն
-20,35 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
212,79 մլն
11,74 մլն
140,90 մլն
126,83 մլն
Gain or loss from assets sale
-365,90 հզր
934,47 հզր
-
-5,69 հզր
AI content may include mistakes. Learn more
Google Apps